Robbins Farley Buys 9,465 Shares of iShares Biotechnology ETF $IBB

Robbins Farley bought a new stake in iShares Biotechnology ETF (NASDAQ:IBB) in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 9,465 shares of the financial services provider’s stock, valued at approximately $1,993,000.

A number of other hedge funds have also added to or reduced their stakes in the business. Bank of America Corp DE lifted its position in iShares Biotechnology ETF by 10.8% during the 1st quarter. Bank of America Corp DE now owns 7,259,501 shares of the financial services provider’s stock worth $1,225,767,000 after buying an additional 707,343 shares in the last quarter. Henshaw Capital LLC acquired a new position in shares of iShares Biotechnology ETF during the 1st quarter worth about $20,262,000. MinichMacGregor Wealth Management LLC grew its holdings in shares of iShares Biotechnology ETF by 3,323.4% in the 3rd quarter. MinichMacGregor Wealth Management LLC now owns 78,396 shares of the financial services provider’s stock valued at $16,505,000 after acquiring an additional 76,106 shares in the last quarter. Redstone Wealth Management LLC bought a new position in shares of iShares Biotechnology ETF in the 3rd quarter valued at about $12,401,000. Finally, The Manufacturers Life Insurance Company grew its holdings in shares of iShares Biotechnology ETF by 64.0% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 101,838 shares of the financial services provider’s stock valued at $19,369,000 after acquiring an additional 39,760 shares in the last quarter. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Up 3.2%

NASDAQ:IBB opened at $210.50 on Wednesday. The stock’s 50-day simple moving average is $207.26 and its 200 day simple moving average is $188.59. iShares Biotechnology ETF has a 52-week low of $153.25 and a 52-week high of $217.12.

iShares Biotechnology ETF Cuts Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, September 18th. Investors of record on Tuesday, September 15th were given a dividend of $0.0112 per share. This represents a $0.04 annualized dividend and a yield of 0.0%. This is a drop from iShares Biotechnology ETF’s previous quarterly dividend of $0.0238. The ex-dividend date of this dividend was Tuesday, September 15th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.